Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure

INTRODUCTION: The administration of systemic corticosteroids is a key strategy for improving COVID-19 outcomes. However, evidence is lacking on combination therapies of antiviral agents and systemic corticosteroids. The objective of this study was to investigate the efficacy and safety of the combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shindo, Yuichiro, Kondoh, Yasuhiro, Kada, Akiko, Doi, Yohei, Tomii, Keisuke, Mukae, Hiroshi, Murata, Naohiko, Imai, Ryosuke, Okamoto, Masaki, Yamano, Yasuhiko, Miyazaki, Yasunari, Shinoda, Masahiro, Aso, Hiromichi, Izumi, Shinyu, Ishii, Haruyuki, Ito, Ryota, Saito, Akiko M., Saito, Toshiki I., Hasegawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349598/
https://www.ncbi.nlm.nih.gov/pubmed/34368914
http://dx.doi.org/10.1007/s40121-021-00512-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349598/
https://www.ncbi.nlm.nih.gov/pubmed/34368914
http://dx.doi.org/10.1007/s40121-021-00512-9

Ejemplares similares